Product Details
GARDASIL Suspension for Intramuscular Injection**
Human Papillomavirus Quadrivalent (Types 6, 11, 16, and 18) L1 Protein Vaccine, Recombinant20 mcg/0.5mL; 40 mcg/0.5mL; 40 mcg/0.5mL; 20 mug/0.5mL
Suspension for injection
ROA
Intramuscular
Applicant Name
MSD IDEA Pharmaceuticals Nigeria Limited
NRN
A6-100120
Status
Active
Composition
Each 0.5-mL dose contains approximately 20 mcg of HPV 6 L1 protein, 40 mcg of HPV 11 L1 protein, 40 mcg of HPV 16 L1 protein, and 20 mcg of HPV 18 L1 protein. Each 0.5-mL dose of the vaccine contains approximately 225 mcg of aluminum (as Amorphous Aluminum Hydroxyphosphate Sulfate adjuvant), 9.56 mg of sodium chloride, 0.78 mg of L-histidine, 50 mcg of polysorbate 80, 35 mcg of sodium borate
ATC Code
J07BM01
Product Category
Vaccines and Biologics
Marketing Category
Prescription-only Medicine (POM)
Packsize
0.5 mL x 10's (in 1.5 mL Type I pre-filled glass syringe)
Product Description
Sterile suspension for injection in a pre-filled syringe. Prior to agitation, Gardasil may appear as a clear liquid with a white precipitate. After thorough agitation, it is a white, cloudy liquid
Manufacturer Name
Merck Sharp & Dohme LLC
Manufacturer Country
UNITED STATES OF AMERICA
Approval Date
2023-07-10
Expiry Date
2028-07-05